MyFinsight
Home
Blog
About
Contact
Download
Download image
Net gain on realized
contingent milestone and...
$75,137K
Trelegy milestone
income
$50,000K
Interest and other
income, net
$10,173K
Future contingent
milestone and royalty...
-$144,200K
Net income (loss)
$105,895K
Share-based compensation
$18,476K
Unrecognized tax benefits
$10,481K
Amortization of right-of-use
assets
$4,015K
Accrued
personnel-related expenses,...
$4,009K
Future royalty payment
contingency interest...
$2,461K
Depreciation and
amortization
$1,626K
Accounts payable
$326K
Prepaid clinical and
development services
-$73K
Other long-term
liabilities
$67K
Loss on disposal of
property and equipment
-$35K
Canceled cashflow
$29,415K
Net cash provided by
(used in) operating...
$238,541K
Canceled cashflow
$53,123K
Provision for income tax
benefit (expense)
$23,352K
Loss from operations
-$3,602K
Interest expense
(non-cash)
$2,461K
Net increase
(decrease) in cash, cash...
$130,009K
Canceled cashflow
$108,532K
Receivables from
collaborative and licensing...
$27,099K
Deferred income taxes
-$11,519K
Operating lease
liabilities
-$7,117K
Other prepaid and
current assets
$3,360K
Amortization and accretion on
investment securities, net
$2,830K
Other assets
$1,077K
Other
$89K
Right-of-use lease assets
$32K
Maturities of marketable
securities
$142,975K
Proceeds from option
exercises
$766K
Proceeds from the sale of
ordinary shares
$20K
Net cash (used in)
provided by investing...
-$105,284K
Net cash used in
financing activities
-$3,248K
Canceled cashflow
$142,975K
Canceled cashflow
$786K
Purchases of marketable
securities
$248,217K
Repurchase of shares to
satisfy tax withholding
$4,034K
Purchases of property and
equipment
$42K
Back
Back
Cash Flow
source: myfinsight.com
Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH)